You need JavaScript to view this

Radiation absorbed dose and expected risk in head and neck tissues after thyroid radioiodine therapy

Abstract

Measurement of absorbed dose in head and neck phantom after applying I-131 therapeutic dose for the treatment of thyroid malignancies was conducted. The measurement were carried out at several sites of phantom using TL dosimeters. The absorbed doses were also measured on the skin of four patients during their administration of I-131 therapeutic doses 1.332 GBq (36 mci) I-131. The measurements were taken over 69 hours exposure at different sites of phantom. The same measurements were carried out on the four patients. At five sites of the patients head and neck, the absorbed dose were measured and compared with that measured on the phantom. The values measured are discussed in the light of the published individual absorbed doses in the organs by ICRP tables. High absorbed doses were absorbed in the different sites of the head and neck during the I-131 therapy (0.14-9.68 mGy/mCi). 3 figs., 2 tabs.
Authors:
Hamed, A; [1]  Farag, H I; [2]  Saleh, A [3] 
  1. National Center for Nuclear and Radiation Control, AEA., Cairo (Egypt)
  2. National Cancer instiute, Cairo University, Cairo (Egypt)
  3. Al-hussien Hospital, Al-Azhar University, Cairo (Egypt)
Publication Date:
Dec 31, 1996
Product Type:
Miscellaneous
Report Number:
INIS-EG-006; CONF-9611191-
Reference Number:
SCA: 550604; 560161; PA: AIX-28:059315; EDB-97:121346; SN: 97001844393
Resource Relation:
Conference: 3. radiation physics conference, Cairo (Egypt), 13-17 Nov 1996; Other Information: PBD: 1996; Related Information: Is Part Of Proceedings of the third Radiation Physics Conference. Vol. 2; Gomaa, M.A.; El-Behay, A.Z.; Hassib, G.M.; El-Naggar, A.M. [eds.]; PB: 419 p.
Subject:
55 BIOLOGY AND MEDICINE, BASIC STUDIES; 56 BIOLOGY AND MEDICINE, APPLIED STUDIES; HEAD; PATIENTS; RADIATION DOSES; THYROID; NECK; ANIMAL TISSUES; EXPERIMENTAL DATA; ICRP; IODINE; IODINE 131; PHANTOMS; SKIN; THERAPY; THERMOLUMINESCENT DOSEMETERS
OSTI ID:
521281
Research Organizations:
Atomic Energy Establishment, Cairo (Egypt)
Country of Origin:
Egypt
Language:
English
Other Identifying Numbers:
Other: ON: DE97639681; TRN: EG9700120059315
Availability:
INIS; OSTI as DE97639681
Submitting Site:
INIS
Size:
pp. 246-254
Announcement Date:

Citation Formats

Hamed, A, Farag, H I, and Saleh, A. Radiation absorbed dose and expected risk in head and neck tissues after thyroid radioiodine therapy. Egypt: N. p., 1996. Web.
Hamed, A, Farag, H I, & Saleh, A. Radiation absorbed dose and expected risk in head and neck tissues after thyroid radioiodine therapy. Egypt.
Hamed, A, Farag, H I, and Saleh, A. 1996. "Radiation absorbed dose and expected risk in head and neck tissues after thyroid radioiodine therapy." Egypt.
@misc{etde_521281,
title = {Radiation absorbed dose and expected risk in head and neck tissues after thyroid radioiodine therapy}
author = {Hamed, A, Farag, H I, and Saleh, A}
abstractNote = {Measurement of absorbed dose in head and neck phantom after applying I-131 therapeutic dose for the treatment of thyroid malignancies was conducted. The measurement were carried out at several sites of phantom using TL dosimeters. The absorbed doses were also measured on the skin of four patients during their administration of I-131 therapeutic doses 1.332 GBq (36 mci) I-131. The measurements were taken over 69 hours exposure at different sites of phantom. The same measurements were carried out on the four patients. At five sites of the patients head and neck, the absorbed dose were measured and compared with that measured on the phantom. The values measured are discussed in the light of the published individual absorbed doses in the organs by ICRP tables. High absorbed doses were absorbed in the different sites of the head and neck during the I-131 therapy (0.14-9.68 mGy/mCi). 3 figs., 2 tabs.}
place = {Egypt}
year = {1996}
month = {Dec}
}